Association Française des Hémophiles

Association Française des Hémophiles
Name	Association Française des Hémophiles
Native name	Association Française des Hémophiles
Abbreviation	AFH
Type	Non-governmental organization
Founded	1968
Headquarters	Paris, France
Region served	France
Fields	Health, Patient advocacy, Rare diseases

Association Française des Hémophiles is a French patient organization representing people with hemophilia and related bleeding disorders, active in advocacy, education, and support across France. It engages with national and international institutions to influence policy, coordinate care pathways, and fund research collaborations. The association interacts with hospitals, pharmaceutical stakeholders, and European patient networks to improve clinical outcomes and quality of life.

History

The association was founded in the late 1960s amid contemporaneous developments involving World Federation of Hemophilia, European Haemophilia Consortium, Ministry of Health (France), Académie Nationale de Médecine, and patient groups in United Kingdom, Germany, Italy. Early decades overlapped with debates involving Haemophilia Centre Directors Organization, Centre hospitalier universitaire de Lyon, Hôpital Necker-Enfants Malades, Hôpital Saint-Louis, and national blood services such as Établissement français du sang. The organization’s history intersects with high-profile legal and public health episodes that involved Cour de cassation (France), Conseil d'État (France), Assemblée nationale, Senate of France, and investigative committees addressing contaminated blood scandals similar to matters seen in United Kingdom inquiries and Canadian proceedings involving Krever Commission. Over time it collaborated with clinical researchers affiliated with Institut Pasteur, Inserm, Université Paris Cité, Université de Strasbourg, Université de Lyon, and specialty networks such as European Association for Haemophilia and Allied Disorders.

Mission and Activities

The association’s mission aligns with international patient advocacy exemplified by World Health Organization, European Commission, European Medicines Agency, United Nations, and European patient directives influenced by Council of Europe. Core activities include liaison with treatment centres like Centre Antoine Lacassagne, partnerships with academic institutions including Université de Montpellier, and engagement with regulatory bodies including Haute Autorité de Santé. It conducts campaigns modelled after initiatives from Red Cross, Médecins Sans Frontières, European Public Health Alliance, and coordinates with national initiatives such as Plan national maladies rares and programs led by Agence nationale de sécurité du médicament et des produits de santé.

Organization and Governance

Governance structures mirror nonprofit frameworks found in organizations such as La Ligue contre le cancer, Fondation ARC pour la recherche sur le cancer, and Fondation de France with a board of directors, executive team, and regional representatives. The association liaises with hospitals like Hôpital Bicêtre, academic centres such as Université Paris-Saclay, and participates in advisory committees to bodies like Direction générale de la Santé. Leadership often includes healthcare professionals associated with Société française d'hématologie, consumer representatives similar to those in UFC-Que Choisir, and legal counsel familiar with rulings from Cour européenne des droits de l'homme.

Membership and Community Services

Membership comprises patients, families, clinicians from institutions like CHU de Bordeaux, CHU de Toulouse, CHU de Nantes, and allied professionals from organisations including Association pour le Don de Sang Bénévole and Association française des diabétiques. Services include peer-support groups modelled on structures in European Haemophilia Consortium, psychosocial assistance referencing programs at Hôpital Necker-Enfants Malades, and training sessions held in partnership with universities like Université Grenoble Alpes. Community outreach extends to regional centres in cities such as Marseille, Lille, Nice, Strasbourg, Rennes, and Caen.

Advocacy and Policy Influence

Advocacy campaigns target policymakers in Assemblée nationale, Région Île-de-France, and health agencies like Haute Autorité de Santé to influence reimbursement and access decisions akin to campaigns by PatientsLikeMe and European Patients' Forum. The association participates in policy dialogues with European Commission working groups, submits dossiers to European Medicines Agency, and collaborates with patient coalitions that have engaged with World Health Organization frameworks. It has engaged in litigation and policy advocacy influenced by legal precedents from Cour de cassation (France) and transnational cases considered by Court of Justice of the European Union.

Research, Education, and Outreach

The association funds and facilitates research consortia with partners such as Inserm, CNRS, Institut Pasteur, Hôpitaux Universitaires de Strasbourg, and pharmaceutical research teams connected to companies that operate in Europe. Educational programs include professional development with Société française d'hématologie, patient education aligned with standards from World Federation of Hemophilia, and school-based outreach similar to programs by UNICEF and Ministry of National Education (France). It organizes conferences in collaboration with entities like European Haemophilia Consortium and academic symposia featuring speakers from Johns Hopkins University, University of Oxford, Harvard Medical School, and Karolinska Institutet.

Partnerships and Funding

Funding sources include grants and partnerships with foundations comparable to Fondation pour la Recherche Médicale, philanthropic bodies such as Fondation Bettencourt Schueller, and cooperative arrangements with industry stakeholders similar to collaborations seen with multinational firms present at European Federation of Pharmaceutical Industries and Associations. Strategic partnerships extend to international NGOs like Red Cross, research institutes such as Broad Institute of MIT and Harvard, and European networks including European Haemophilia Consortium and World Federation of Hemophilia. The association’s financial oversight aligns with standards applied by Cour des comptes and nonprofit reporting practices used by Fondation de France.

Category:Medical and health organizations based in France